Xu Ju-Ping, Ding Xue-Ying, Guo Shi-Qi, Wang Hui-Ying, Liu Wei-Jia, Jiang Hui-Min, Li Ya-Dong, Fu Ping, Chen Ping, Mei Yu-Shuo, Zhang Guo, Zhou Hai-Bo, Jing Jian
State Key Laboratory of Pharmaceutical Biotechnology, Jiangsu Engineering Research Center for MicroRNA Biology and Biotechnology, Chemistry and Biomedicine Innovation Center, Institute for Brain Sciences, Advanced Institute for Life Sciences, School of Life Sciences, Chinese Academy of Medical Sciences Research Unit of Extracellular RNA, Nanjing University, Nanjing, Jiangsu, China.
School of Electronic Science and Engineering, Nanjing University, Nanjing, Jiangsu, China.
Front Pharmacol. 2023 Mar 20;14:1132066. doi: 10.3389/fphar.2023.1132066. eCollection 2023.
The vasopressin/oxytocin signaling system is present in both protostomes and deuterostomes and plays various physiological roles. Although there were reports for both vasopressin-like peptides and receptors in mollusc and Octopus, no precursor or receptors have been described in mollusc . Here, through bioinformatics, molecular and cellular biology, we identified both the precursor and two receptors for vasopressin-like peptide, which we named vasotocin (apVT). The precursor provides evidence for the exact sequence of apVT, which is identical to conopressin G from cone snail venom, and contains 9 amino acids, with two cysteines at position 1 and 6, similar to nearly all vasopressin-like peptides. Through inositol monophosphate (IP1) accumulation assay, we demonstrated that two of the three putative receptors we cloned from cDNA are true receptors for apVT. We named the two receptors as apVTR1 and apVTR2. We then determined the roles of post-translational modifications (PTMs) of apVT, i.e., the disulfide bond between two cysteines and the C-terminal amidation on receptor activity. Both the disulfide bond and amidation were critical for the activation of the two receptors. Cross-activity with conopressin S, annetocin from an annelid, and vertebrate oxytocin showed that although all three ligands can activate both receptors, the potency of these peptides differed depending on their residue variations from apVT. We, therefore, tested the roles of each residue through alanine substitution and found that each substitution could reduce the potency of the peptide analog, and substitution of the residues within the disulfide bond tended to have a larger impact on receptor activity than the substitution of those outside the bond. Moreover, the two receptors had different sensitivities to the PTMs and single residue substitutions. Thus, we have characterized the vasotocin signaling system and showed how the PTMs and individual residues in the ligand contributed to receptor activity.
血管加压素/催产素信号系统存在于原口动物和后口动物中,并发挥着多种生理作用。尽管有报道称软体动物和章鱼中存在血管加压素样肽和受体,但在软体动物中尚未描述其前体或受体。在这里,通过生物信息学、分子和细胞生物学,我们鉴定出了血管加压素样肽的前体和两种受体,我们将其命名为血管催产素(apVT)。该前体为apVT的精确序列提供了证据,其与芋螺毒液中的芋螺毒素G相同,包含9个氨基酸,在第1和第6位有两个半胱氨酸,这与几乎所有血管加压素样肽相似。通过肌醇单磷酸(IP1)积累测定,我们证明了从cDNA克隆的三个推定受体中的两个是apVT的真正受体。我们将这两个受体命名为apVTR1和apVTR2。然后,我们确定了apVT翻译后修饰(PTM)的作用,即两个半胱氨酸之间的二硫键和C末端酰胺化对受体活性的影响。二硫键和酰胺化对于两种受体的激活都至关重要。与芋螺毒素S、来自环节动物的沙蚕素和脊椎动物催产素的交叉活性表明,尽管所有三种配体都可以激活两种受体,但这些肽的效力因其与apVT的残基差异而有所不同。因此,我们通过丙氨酸替代测试了每个残基的作用,发现每个替代都可以降低肽类似物的效力,并且二硫键内残基的替代对受体活性的影响往往比键外残基的替代更大。此外,两种受体对PTM和单个残基替代具有不同的敏感性。因此,我们对血管催产素信号系统进行了表征,并展示了配体中的PTM和单个残基如何影响受体活性。